CompletedPhase 4

The Efficacy of Amnion Chorion Allograft in Management of Gingival Recession.

Egypt28 participantsStarted 2024-08-01

Plain-language summary

the main goal of this clinical trial is to test the efficacy of amnion Chorion allograft in managing gingival recession. The main questions it aims to answer are: Is it effective in treating gingival recession, and how it compares to connective tissue graft.

Who can participate

Age range25 Years – 45 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. Selected patients of both sexes are 25-45 years old.
✓. Patients are systemically healthy based on the questionnaire dental modification of the Cornell index.
✓. O'Leary index (1972) is less than 10% (the surgical therapy is not initiated until the patient reaches the 10% level or less of plaque accumulation).
✓. Buccal recession defects are classified RT1 according to Cairo's classification (2011).
✓. Clinical indication and/or patient request for recession coverage.

Exclusion criteria

✕. RT2 and RT3 recession defects.
✕. Pregnant female.
✕. Smokers.
✕. Patients with special needs or with any mental problems.
✕. All patients are using any kind of medication that could interfere with the healing of periodontal tissues. Such as chemotherapy and radiotherapy.
✕. Teeth with root carious lesions.
✕. Rotated and extruded teeth.
✕. Patients underwent any prior periodontal surgery in the relevant region.

What they're measuring

recession depth

Timeframe: changes in millimeters from base line to follow up after 6 months

Trial details

NCT IDNCT06508476

SponsorMinia University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-01-31

View on ClinicalTrials.gov More Gingival Recession, Localized trials